Intravenous vasopressin in patients with portal hypertension: advantages of continuous infusion.
D000005:Abdomen; D000328:Adult; D001794:Blood Pressure; D002302:Cardiac Output; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006261:Headache / Q000139:chemically induced; D006339:Heart Rate; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009120:Muscle Cramp / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D014667:Vasopressins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D014667:Vasopressins